Phase 2 Randomized, Placebo-Controlled Trial to Evaluate the Safety and Immunogenicity of a Chikungunya Virus-Like Particle Vaccine, VRC-CHKVLP059-00-VP, in Healthy Adults
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 25 Jun 2018
At a glance
- Drugs VRC-CHKVLP059-00-VP (Primary)
- Indications Chikungunya virus infections
- Focus Adverse reactions
- 15 Jun 2018 Planned End Date changed from 1 Dec 2017 to 1 Oct 2018.
- 15 Jun 2018 Planned primary completion date changed from 1 Sep 2017 to 1 Oct 2018.
- 18 Jan 2017 New trial record